SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from MetaVia Inc. (MTVA) (CIK 0001638287) (MTVA) — Jul 8, 2016

MetaVia Inc. (MTVA) (CIK 0001638287)
Date: July 8, 2016 · CIK: 0001638287 · Accession: 0001104659-16-131760

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-210815

Date
July 8, 2016
Author
/s/ MINA SOOCH
Form
CORRESP
Company
MetaVia Inc. (MTVA) (CIK 0001638287)

Letter

July 8, 2016

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, NE

Washington, D.C. 20549

Attention: Suzanne Hayes

Joshua Samples

Lilyanna Peyser

Sharon Blume

Sasha Parikh

Re: Gemphire Therapeutics Inc.

Registration Statement on Form S-1

File No. 333-210815

Ladies and Gentlemen:

Effective immediately, the undersigned withdraws the request for acceleration sent to your office via EDGAR on June 20, 2016, which requested that the Commission take appropriate action to cause the above-referenced Registration Statement to become effective at 4:00 p.m. Eastern Time on June 22, 2016 or as soon as practicable thereafter.

[signature page follows]

Sincerely,
GEMPHIRE THERAPEUTICS INC.

Show Raw Text
CORRESP
1
filename1.htm

July 8, 2016

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, NE

Washington, D.C. 20549

Attention:              Suzanne Hayes

Joshua Samples

Lilyanna Peyser

Sharon Blume

Sasha Parikh

Re:          Gemphire Therapeutics Inc.

Registration Statement on Form S-1

File No. 333-210815

Ladies and Gentlemen:

Effective immediately, the undersigned withdraws the request for acceleration sent to your office via EDGAR on June 20, 2016, which requested that the Commission take appropriate action to cause the above-referenced Registration Statement to become effective at 4:00 p.m. Eastern Time on June 22, 2016 or as soon as practicable thereafter.

[signature page follows]

Sincerely,

GEMPHIRE THERAPEUTICS INC.

/s/ MINA SOOCH

Mina Sooch

President, Chief Executive Officer   and Treasurer

cc:           Phillip D. Torrence, Honigman Miller Schwartz and Cohn LLP

Meredith Ervine, Honigman Miller Schwartz and Cohn LLP

Gabrielle L. Sims, Honigman Miller Schwartz and Cohn LLP

Divakar Gupta, Cooley LLP

Charles S. Kim, Cooley LLP

Siana E. Lowrey, Cooley LLP